Global Sciatica Treatment Market

Sciatica Treatment Market Size, Share, Growth Analysis, By Drug class(Non-steroidal anti-inflammatory drugs, Steroids), By Type(Acute sciatica, Chronic sciatica), By Distribution channel(Hospital pharmacies, Retail & specialty pharmacies) - Industry Forecast 2024-2031

Report ID: SQMIG35A2822 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 90 | Figures: 72

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Sciatica Treatment Market size was valued at USD 705.80 billion in 2022 and is poised to grow from USD 734.74 billion in 2023 to USD 1013.30 billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

The competitive environment of the Sciatica Treatment market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Abbott Laboratories(United States)', 'Johnson and Johnson (United States)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Aurobindo Pharma Ltd. (India)', 'Zydus Cadila(India)', 'Glenmark Pharmaceuticals Ltd. (India)', 'Amneal Pharmaceuticals LLC (United States)', 'Jubilant Life Sciences Ltd. (India)', 'Hikma Pharmaceuticals PLC. (United Kingdom)', 'Mylan N.V.(Netherlands)', 'Horizon Therapeutics Plc. (Ireland)', 'Sun Pharmaceutical Industries Ltd. (India)', 'Alkem Labs (India)', 'SCILEX Pharmaceuticals, Inc (United States)', 'Seikagaku Corporation (Japan)', 'Kolon Life Science, Inc. (South Korea)'

Sciatica is a common condition that affects up to 43% of the population throughout their lifetime, affecting approximately 10-40% of the population, with higher rates seen in older age. Both chronic and acute sciatica, an increase in individuals acts as a key driver of growth of the sciatica treatment market. According to the study, sciatica affects a large percentage of the general population, ranging from 10-40%, and increases in age groups have been accomplished Notably, adults aged 20-59 exhibit a prevalence of 13.1%, while those aged 60 and older 19.2% incidence rate, highlighting the increasing impact of population age.

Advances in diagnostic and imaging technology, particularly MRI and CT scans, have had a transformative effect on the treatment of sciatica. These technological innovations have revolutionized the diagnosis of the causes of sciatica, enabling faster and more accurate diagnosis and early intervention. Early diagnosis is essential to prevent progression of chronic weakness. Improved accuracy in diagnosis, due to advanced imaging technology, positively impacts the clinical landscape by empowering healthcare professionals to intervene faster and more effectively, not that this provides not only improves patient outcomes, but also prevents the longevity of the condition and associated disability. Consequently, the increasing prevalence of sciatica acts as a key driver for the growth of the sciatica treatment market.

North America is expected to witness the largest growth, with a projected compound annual growth rate (CAGR) of 15.6% during the forecast period by 2022. This robust growth is due to the high prevalence of sciatica in North America, supported by better services and payment management. All these factors contribute to the expanding sciatica treatment market in North America. Notably, nonsteroidal anti-inflammatory drugs (NSAIDs) represent the most commonly prescribed category for sciatica treatment, known for their laboratory availability.

Related Reports

Minimally Invasive Thoracic Surgery Market
Buy Now GET FREE SAMPLE
Bioprocess Containers Market
Buy Now GET FREE SAMPLE
Oncology Information Systems Market
Buy Now GET FREE SAMPLE
Veterinary POC Diagnostics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Sciatica Treatment Market

Product ID: SQMIG35A2822

$5,300
BUY NOW